Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.5350 (10%) ($7.5350 - $7.5350) on Mon. Sep. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 54 | Latest Price | $7.5350(10%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XOP(42%) USO(87%) OIH(45%) MCHI(24%) XLE(36%) | Factors Impacting BCRX price | BCRX will decline at least -1.62% in a week (0% probabilities). JETS(-93%) JNK(-86%) IYT(-85%) IWC(-72%) PCY(-69%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.05(6.88%) | 10 Day Moving Average | $7.01(7.49%) | 20 Day Moving Average | $7.1(6.13%) | To recent high | -4.4% | To recent low | 12.5% | Market Cap | $1.329b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |